161 related articles for article (PubMed ID: 26214170)
1. Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry.
Kang KY; Jeon CH; Choi SJ; Yoon BY; Choi CB; Lee CH; Suh CH; Lee CW; Cho CS; Nam EJ; Koh EM; Kim HY; Choi HJ; Kim HA; Jun JB; Lee J; Kim J; Ji JD; Min JK; Kim KJ; Shin K; So MW; Kwon SR; Kim SK; Nah SS; Kwok SK; Lee SK; Lee SW; Park SH; Park W; Park YB; Lee YH; Lee SS; Yoo DH
Int J Rheum Dis; 2017 Sep; 20(9):1227-1236. PubMed ID: 26214170
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ; Korkmaz C
Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
[TBL] [Abstract][Full Text] [Related]
3. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
Kuwana M; Blair C; Takahashi T; Langley J; Coghlan JG
Ann Rheum Dis; 2020 May; 79(5):626-634. PubMed ID: 32161055
[TBL] [Abstract][Full Text] [Related]
4. Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.
Cavagna L; Codullo V; Ghio S; Scirè CA; Guzzafame E; Scelsi L; Rossi S; Montecucco C; Caporali R
Medicine (Baltimore); 2016 Sep; 95(39):e4827. PubMed ID: 27684814
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!
Sanges S; Sobanski V; Lamblin N; Hachulla E; Savale L; Montani D; Launay D
Rev Med Interne; 2024 Jan; 45(1):26-40. PubMed ID: 37925256
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease.
Suzuki Y; Nagaoka T; Terayama Y; Nagata Y; Yoshida T; Tsutsumi T; Kuriyama S; Matsushita M; Joki Y; Takasu K; Konishi H; Takahashi K
Respir Investig; 2024 Jan; 62(1):167-175. PubMed ID: 38142548
[TBL] [Abstract][Full Text] [Related]
7. Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients' prognosis.
Huang J; An Q; Shi H; Li C; Zhang W; Wang L
Clin Rheumatol; 2023 Nov; 42(11):3131-3142. PubMed ID: 37382842
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
Distler O; Ofner C; Huscher D; Jordan S; Ulrich S; Stähler G; Grünig E; Held M; Ghofrani HA; Claussen M; Lange TJ; Klose H; Rosenkranz S; Vonk-Noordegraaf A; Vizza CD; Delcroix M; Opitz C; Pausch C; Scelsi L; Neurohr C; Olsson KM; Coghlan JG; Halank M; Skowasch D; Behr J; Milger K; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Wilkens H; Pittrow D; Hoeper MM; Ewert R
Rheumatology (Oxford); 2024 Apr; 63(4):1139-1146. PubMed ID: 37462520
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
Thoreau B; Mouthon L
Autoimmun Rev; 2024 Apr; 23(4):103506. PubMed ID: 38135175
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
Kularatne M; Boucly A; Savale L; Solinas S; Cheron C; Roche A; Jevnikar M; Jaïs X; Montani D; Humbert M; Sitbon O
Expert Opin Pharmacother; 2023; 24(18):2101-2115. PubMed ID: 37869785
[TBL] [Abstract][Full Text] [Related]
11. 10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry.
Chen X; Quan R; Qian Y; Yang Z; Yu Z; Zhang C; Yang Y; Zhang G; Shen J; Wang Q; Gu Q; Xiong C; Jing X; Han H; He J
Rheumatology (Oxford); 2023 Nov; 62(11):3555-3564. PubMed ID: 36912696
[TBL] [Abstract][Full Text] [Related]
12. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
Sargent T; Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Cloutier M; Lefebvre P
Adv Ther; 2023 Nov; 40(11):5037-5054. PubMed ID: 37728697
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension.
Nakayama K; Nakajima Y; Tanaka R; Hirata KI; Emoto N
J Clin Rheumatol; 2021 Dec; 27(8):e371-e377. PubMed ID: 32511146
[TBL] [Abstract][Full Text] [Related]
14. Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.
Channick R; Chin KM; McLaughlin VV; Lammi MR; Zamanian RT; Turricchia S; Ong R; Mitchell L; Kim NH
Cardiol Ther; 2024 Jun; 13(2):315-339. PubMed ID: 38451426
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis.
Erdogan M; Esatoglu SN; Kilickiran Avci B; Hatemi G
Intern Emerg Med; 2024 Apr; 19(3):731-743. PubMed ID: 38378970
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry.
Luo Y; Gordon JK; Xu J; Kolstad KD; Chung L; Steen VD; Bernstein EJ;
Rheumatology (Oxford); 2024 May; 63(5):1251-1258. PubMed ID: 37478347
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis.
Budhram B; Weatherald J; Humbert M
Semin Respir Crit Care Med; 2024 Jun; 45(3):419-434. PubMed ID: 38499196
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacies of selective vasodilators in pulmonary arterial hypertension: a comprehensive comparison using a spontaneous reporting database.
Suzuki K; Yagi T; Kawakami J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4981-4992. PubMed ID: 38180559
[TBL] [Abstract][Full Text] [Related]
19. Patient characteristics, diagnostic testing, and initial treatment profiles of patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) using a Japanese claims database.
Tokushige N; Hayashi Y; Omura J; Jinnai T; Atsumi T
Mod Rheumatol; 2024 Apr; ():. PubMed ID: 38581672
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of antinuclear antibodies in patients with suspected connective tissue disease for the development of connective tissue diseases.
Brunekreef TE; van den Heuvel HB; Limper M; Leavis H; van Laar JM; Otten H
Clin Exp Rheumatol; 2024 Jan; 42(1):24-29. PubMed ID: 38079340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
